Lipid Therapy
Intervention program increased prescription rate of lipid modifying therapy
Published in Medical Letter on the CDC and FDA, October 2nd, 2005
According to the report from the United States, "Recent clinical trials indicate that treatment with lipid modifying therapy improves outcomes in patients with ischemic heart disease (IHD) and low levels of high density lipoprotein (HDL) cholesterol. The results of these trials, however, have not been widely implemented in clinical practice."
H.E. Bloomfield and colleagues of the VA Medical Center in Minneapolis wrote, "[Our objective was] to develop and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Addiction Medicine
Prevalence of crack-cocaine injection in U.S. drug users reported - Antimicrobial Resistance
Susceptibility testing method for aquatic bacteria standardized - Gastroschisis
Epidemiology of gastroschisis in metropolitan Atlanta reported - Myelodysplastic Syndrome
Azacitidine for treatment of myelodysplastic syndrome summarized - Polymerase Chain Reaction
PCR assay for dual detection of bacteria and parasites developed - Adverse Drug Reaction
Prolonged linezolid for TB associated with anemia and peripheral neuropathy - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
